J Health Commun by Shone, Laura P. et al.
Misunderstanding and Potential Unintended Misuse of 
Acetaminophen among Adolescents and Young Adults
Laura P. Shone, DrPH, MSW,
University of Rochester Medical Center, Department of Pediatrics
Jennifer P. King, MPH,
Northwestern University Feinberg School of Medicine, Department of General Internal Medicine
Cindy Doane, MSPH,
University of Rochester Medical Center, Department of Pediatrics
Karen M. Wilson, MD, MPH, and
University of Rochester Medical Center, Department of Pediatrics
Michael S. Wolf, PhD, MPH, MS
Northwestern University Feinberg School of Medicine, Department of General Internal Medicine
Abstract
Purpose—Acetaminophen is highly accessible yet potentially dangerous when used incorrectly. 
In attempts to address concerns about acetaminophen, The U.S. Food and Drug Administration 
(FDA) has identified gaps in evidence about unintentional misuse among adolescents. Therefore, 
our objectives were to assess: adolescents’: 1) health literacy; 2) knowledge about acetaminophen; 
3) recent use of over-the-counter (OTC) medicines; 4) and use of medication dosing instructions to 
understand the medicine and how to use it (‘acetaminophen skills’).
Methods—Subjects and Setting: We conducted a cross-sectional survey of adolescents and 
young adults (ages 16–23 years) recruited from education settings and health care sites in Monroe 
County, New York, from 11/08–9/09. Measures: Using structured in-person interviews, we 
assessed acetaminophen knowledge and recent use of over-the-counter (OTC) medicines. We 
assessed participants’ ability to identify acetaminophen in OTC products and answer questions 
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about instructions for acetaminophen use through role-plays of everyday health scenarios. We 
measured health literacy with the Rapid Estimate of Adult Literacy in Medicine (REALM) for 
participants >18, and the REALM-Teen for those <18.
Results—Confusion about acetaminophen and its use was common. Limited health literacy was 
an independent risk factor for poor knowledge, misunderstanding, and potential unsafe use of 
acetaminophen-containing medicines, however, most participants at all health literacy levels erred 
dangerously in ‘unsafe’ understanding of acetaminophen use from label instructions.
Conclusions—Individuals with limited health literacy may face disproportionate risk of unsafe 
use of acetaminophen due to confusion and misunderstanding of label information. Better 
labeling, public health programs, and educational efforts could facilitate safer use of 
acetaminophen.
Keywords
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Introduction
Medication errors in ambulatory care have received increasing attention as patients assume a 
greater role in self-administering their medicines. According to the 2006 Institute of 
Medicine (IOM) report, Preventing Medication Error, approximately one third of the annual 
1.5 million preventable adverse drug events occur in outpatient settings, at a conservative 
cost to the healthcare system of $1 billion annually.(1) Health literacy investigations have 
found that misunderstanding of dosing instructions on prescription drug labels is common. 
This misunderstanding has been cited as a leading root cause of known outpatient 
medication errors and adverse events.(2–6)
Far less is known about the prevalence and root causes of patient misunderstanding of non-
prescription, or ‘over-the-counter’ (OTC) medication label instructions, yet the frequency of 
OTC medicine use may eclipse that of prescription medicines. According to the National 
Council on Patient Information and Education, 59% of Americans reported having taken an 
OTC drug in the last six months, which is slightly more than those reporting use of a 
prescription medicine (54%).(7) However, unlike prescription medications, no guidance or 
intervention from a physician or pharmacist is provided for OTC medications unless the 
patient requests assistance. The potential for error and adverse events could therefore be far 
greater than with prescription drugs.
Use of OTC medicines is similarly common among adolescents; with 78% of adolescents in 
one study reporting use of OTC medicines within the past month.(8) Self-administration of 
OTC medicines among adolescents can begin by ages 11–12 years, increasing markedly 
with each grade-level from grades seven to nine.(9) Adolescents’ self-administration of OTC 
medicines for pain is common, with half to ¾ of junior high students (7th thru 9th grades) in 
a Canadian study reporting that they used OTC medication for pain relief without first 
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checking with an adult.(9) Furthermore, checking with an adult does not ensure safety; 
misinterpretation of OTC labels is also common among parents.(10)
Evidence suggests that the use of certain OTC drugs is causing significant harm. Studies 
have shown that consumers may misuse acetaminophen, a common ingredient in OTC 
analgesics as well as prescription products. Acetaminophen overdose has surpassed viral 
hepatitis as the leading cause of acute liver failure in the United States,(11–13) and may 
cause more deaths by overdose each year than any other pharmaceutical product.(14) 
Moreover, one half to two-thirds of overdoses that have led to acute liver failure are 
unintentional, suggesting the root cause may be poor understanding of medication labeling 
or failure to recognize the consequences of exceeding the recommended maximum daily 
dosage.(11–13) To address the growing concern of acetaminophen misuse, in June 2009 the 
U.S. Food and Drug Administration (FDA) convened a panel to discuss the maximum dose 
recommendations of acetaminophen found in non-prescription medications. The panel 
identified notable gaps in evidence about consumer understanding and use of OTC 
acetaminophen products in general, and about unintentional misuse among adolescents 
specifically.
Misunderstanding of acetaminophen toxicity may also be more common among adolescents 
than among adults. One study of over 1,000 British and American teens found that teens 
may markedly overestimate the size of a lethal dose of acetaminophen,(15) while others 
have found that teens may not comprehend that it is possible to ingest a lethal amount of 
acetaminophen.(16–18) Motivated by the potential risks of acetaminophen and evidence that 
adolescents may commonly self-administer pain medicines without parental oversight, we 
examined understanding of acetaminophen among a sample of adolescents and young 
adults. Individuals in this age range can access OTC medicines without adult supervision, 
yet may still be developing their health skills, including early perceptions and understanding 
of how to safely use non-prescription products.
Patients and Methods
Participants and Procedure
We recruited 266 youth (16–23 yrs) for in-person interviews from 4 education and 2 health 
care sites in Monroe County, NY from November 2008 to September 2009. Education sites 
included an urban public high school, a vocational training center, graduate –equivalency 
(GED) programs, and a community college. Health care sites included a teen clinic and a 
hospital-based ambulatory clinic. Collectively, these sites are representative of 16–23 year-
olds from urban, suburban, and rural areas and a range of socioeconomic levels.
Across the performance sites, we used a combination of consecutive subject recruitment and 
promotional study flyer postings. Consistent with privacy policies, potential participants 
were identified by others (i.e.: health care staff or teachers) and referred to the on-site 
interviewer during a rotating schedule of clinic sessions or classroom sessions. We used a 
rotating rather than a fixed schedule to vary days of the week and times of day and better 
distribute recruitment across a representative range of clinic and/or classroom sessions. We 
also posted English-language flyers in common areas (i.e.: waiting room, student gathering 
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areas), inviting youth to self-identify to the on-site interviewer to participate in a study about 
how adolescents and young adults understand health information and what they find 
confusing. We used quota sampling strategies, based on local demographic data, to distribute 
our sample across age and gender categories and setting, with preset quotas by age, gender, 
and site (health care versus education). The interviewers completed eligibility screening (for 
age and ability to speak English) and obtained verbal informed consent. We conducted this 
minimal-risk study with a waiver of documentation of consent and a waiver of Health 
Insurance Portability and Accountability Act (HIPAA) authorization, thus no parental 
consent was required and study participation was completely anonymous (neither individual 
identifiers nor personal health information were collected, however, because some of our 
recruitment took place in health care settings, a HIPAA authorization was required). This 
approach was essential to preserve the confidentiality of medical visits made by participants 
who were recruited at health care sites. Participants received a free movie ticket upon 
completion of the interview. The study was approved by the Institutional Review Board of 
the University of Rochester and appropriate review boards at each participating site.
Measures
Interviews took between 30 and 45 minutes, beginning with health literacy assessment. 
Participants were given as much time as they needed to complete the interview at a 
comfortable pace. We used structured in-person interviews to measure demographic 
characteristics and to assess recent use of OTC medicines and acetaminophen knowledge. 
We provided participants with seven OTC package props and asked them to: 1) identify the 
active ingredient in Tylenol™; 2) demonstrate understanding of Tylenol™ dosing 
instructions; and 3) distinguish acetaminophen containing products from non-containing 
products. We measured health literacy using the Rapid Estimate of Adult Literacy in 
Medicine (REALM) for participants > 18 and the REALM-Teen for those < 18. The 
REALM is the most commonly used test of patient literacy in medical settings.(19) Health 
literacy is categorized as “limited” or “adequate”.(20) We asked respondents to self-define 
their race and ethnicity per the following: “Which one of the following best describes your 
race?” (Black, White, Asian/Pacific Islander, or Other) and “Are you Hispanic or Latino?”
Recent use of OTC medicines—Before asking about any specific medicines, we asked 
about participants’ use of OTC medicines within the past month (Within the past month, 
have you taken any over-the-counter medicines?; What medicine(s) did you take?; How long 
ago did you last use an over-the-counter medicine?). From this list, we measured 
acetaminophen use by comparing the self-reported list of OTC medicines used in the last 
month to the list of active ingredients found on the products’ manufacturers’ websites. If 
detail was insufficient to distinguish between an acetaminophen-containing and non-
containing version of the same medicine, we considered the medicine to be acetaminophen-
free.
Acetaminophen knowledge and understanding of labeling information—We 
assessed respondents’ familiarity with acetaminophen, ability to recognize acetaminophen-
containing products, and understanding of label information on a package of Tylenol™. We 
first asked whether respondents had ever heard of acetaminophen. We then handed the 
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participant a set of five OTC medicine packages, including Tylenol,™ and assessed whether 
they could identify the active ingredient based on the package label information (some 
products contained acetaminophen; others did not). We assessed participants’ understanding 
of Tylenol™ dosing instructions using a previously-validated set of questions about the label 
information, including: 1) How many pills are in one dose?; 2) How many doses of 
Tylenol™ could be taken during the course of one day?; and 3) If you took the highest dose 
of Tylenol™ you should take in one day, starting at 8 AM, what time would you take each 
dose and how many pills would you take each time? (the interviewer used prompts to walk 
the participant through the sequence from ‘first’ to ‘next’ and so on). Responses were 
categorized as ‘correct’ if they matched the instructions provided on the package (i.e. two 
pills per dose, four doses per day, four, five or six hours between doses and eight pills in 24 
hours), ‘over’ if the sum of responses was larger, and ‘under’ if the sum of responses was 
smaller. We created categories to represent ‘don’t know’ (if the respondent said ‘don’t know’ 
or did not give an answer) and ‘inappropriate’ to categorize responses that did not answer 
the question (for example, a response of “500 mg” to a question about number of pills would 
be coded ‘inappropriate’). Following the Tylenol™-specific questions, we presented 
packages for seven common OTC medicines (Tylenol™, Bayer™, Motrin™, Sudafed™ PE 
Sinus Headache, DayQuil™, Sudafed™ Nasal Decongestant (pseudoephedrine HCl), and 
Sudafed™ PE Cold/Cough) and asked participants: 1) whether any of them contained 
acetaminophen; and 2) (if yes) which ones [contained acetaminophen].
We created additional variables for use in multivariate analyses. We created the dichotomous 
variable “safe” (or unsafe) by combining the: a) number of pills in one dose, b) number of 
doses in one day and c) interval between hypothetical doses, to represent performance on 
dosing tasks as a whole. We coded this variable as ‘unsafe’ if at least one of the measures 
was incorrect and placed the participant at risk of overdosing. Examples of ‘unsafe’ 
responses include: >2 pills per dose, >4 doses per day, intervals shorter than 4 hours between 
doses, or ’don’t know’ or ‘inappropriate’ responses to any of the three prompts. In contrast, 
we coded responses as ‘safe’ if the participant indicated that they would take: ≤2 pills per 
dose, ≤4 doses per day, at intervals of ≥4 hours between doses. We also created the 
dichotomous variable “over” (or under) to represent potential overdose. From the four levels 
of maximum daily dose, we combined: 1) ‘don’t know’ with ‘over’; and 2) ‘under’ with 
‘correct’ to distinguish maximum daily doses that could exceed safe limits within 24 hours 
from those that were within or below safe limits.
Analyses
We used Chi-square tests to bivariate associations between: 1) health literacy level (limited, 
adequate) and the sociodemographic and OTC use variables (Table 1); and between health 
literacy and the measures of acetaminophen knowledge and dosing skills (Table 2).
We generated multivariate models to assess the associations of health literacy, 
sociodemographic characteristics and prior OTC use with 1) failure to identify 
acetaminophen as the active ingredient in Tylenol™, 2) unsafely completing dosing tasks 
and 3) exceeding the maximum dose in 24 hours. We did not use logistic regression because 
each of these outcome variables had a high percentage of responses in one category (either 
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most ‘yes’ or most ‘no’), and estimated odds ratios from logistic regression could 
overestimate the associations. Instead, we used generalized linear models with a Poisson 
distribution and log link function with robust variance estimates to estimate prevalence ratios 
with 95% confidence intervals.(21, 22) We used STATA SE Version 10.1 for all analyses.
(23)
Results
We interviewed 266 respondents. Over half were female (56.4%). Slightly less than half 
identified themselves as non-Hispanic white (47.4%) and just over a third (36.1%) had 
private health insurance. The mean (SD) age of respondents was 18.6 (2.0) years, two-thirds 
had not completed high school, and 36% had limited health literacy (Table 1). Overall, 74% 
of respondents had used OTC medicines within the past month. Sixty-four percent of all 
respondents had never heard of acetaminophen, yet 33% of those (21% of all respondents) 
had unknowingly used one or more acetaminophen-containing products within the past 
month. In contrast, 13% of all respondents had heard of acetaminophen and used it within 
the past month (Table 2).
Also shown in Table 2, most participants could identify acetaminophen as the active 
ingredient in Tylenol (86%), however, there were significant differences by health literacy 
level, with poorer outcomes among those whose health literacy was limited. We found 
significant differences by health literacy for all measures -- the dosing tasks individually as 
well as the summary variable that evaluated performance across all knowledge tasks. Nearly 
94% of those with limited health literacy and 79% of those with adequate health literacy 
unsafely completed at least one of the acetaminophen knowledge measures, for a total of 
nearly 85% of participants ‘unsafe’ overall (p=.002). We also found differences in the ability 
to correctly distinguish acetaminophen-containing products from products that did not 
contain acetaminophen, with 65% of those with adequate health literacy and 37% of 
respondents with limited health literacy correctly distinguishing all acetaminophen-
containing products (p<0.001). One-third of respondents overall correctly distinguished 
some products but not all, with no difference by health literacy level, and one-third of 
respondents with inadequate health literacy failed to correctly identify any of the products 
that contained acetaminophen (Table 2).
In multivariate analyses, limited health literacy (Adjusted Relative Risk (ARR) 7.37, 95% CI 
3.02–18.0), having public health insurance (ARR 2.50, 95%CI 1.16–5.40) and not using an 
OTC in the last month (ARR 1.83, 95%CI 1.10–3.05) were significant independent 
predictors for incorrectly identifying the active ingredient in Tylenol™. Limited health 
literacy (ARR 1.13, 95%CI 1.00–1.28) was also an independent predictor for unsafely 
completing the dosing tasks; along with non-Hispanic black race (ARR 1.16, 95%CI 1.01–
1.34) and other race (ARR 1.31, 95%CI 1.11–1.54). Female gender (ARR 1.87, 95%CI 
1.15–3.06) was a predictor of exceeding the maximum dose of medicine in 24 hours, while 
being uninsured (ARR 0.33, 95%CI 0.11–0.98) was found to protect against exceeding the 
maximum dose (Table 3).
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Misunderstanding of many aspects of acetaminophen use was common in our sample of 
adolescents and young adults, and limited health literacy was an independent risk factor for 
poor knowledge, misunderstanding, and potential unsafe use of OTC medicines that contain 
acetaminophen. Given the established dangers of acetaminophen overdose,8–10 the wide 
range of acetaminophen-containing products available over-the-counter, and the increase in 
autonomy of adolescents and young adults in caring for their own health including self-
administration of medicines, our findings suggest that this may be a major public health 
concern.
Specific elements of label instructions may be particularly confusing for adolescents and 
young adults, namely, the ‘active ingredient’ and the ‘dosing instructions’. With regard to 
the active ingredient, more than one-fifth of our respondents reported recent use of OTC 
products that contain acetaminophen, yet said they had never heard of acetaminophen itself. 
However, when we handed them a package and asked them to identify the active ingredient, 
most of our respondents could identify it as acetaminophen. There are several ways to 
interpret these findings. Individuals may: 1) misread or misunderstand label information; 2) 
read and understand label information yet later misremember the details; or 3) be 
unaccustomed to reading or unable to read label information at all. Second, with regard to 
dosing, most participants in our study were unable to correctly identify the number of doses 
to take in one day. The overwhelming majority of respondents (85% overall), erred 
dangerously, in ‘unsafe’ understanding of acetaminophen use. Although error was prevalent 
at both levels of health literacy, those with limited health literacy were still significantly 
more likely to report ‘unsafe’ error compared with those whose health literacy was adequate. 
Both of these findings point toward label instructions as a potential root cause of confusion 
about safe use of acetaminophen.
Both public insurance and black race were independent predictors of misunderstanding. It is 
possible that both of these covariates address socioeconomic status (SES), which may 
explain less familiarity and less use of OTC products. As in other health literacy studies as 
well as national surveys of general literacy, SES and minority race/ethnicity are both 
strongly linked to poorer reading and numeracy skills. In contrast, another socioeconomic 
indicator, lack of health insurance, was protective against exceeding the maximum dose of 
acetaminophen in 24 hours. It is possible that those with limited means may be accustomed 
to using less medicine, to conserve OTC medicines by taking fewer pills per dose or waiting 
longer intervals between doses.
Our study has notable limitations. We excluded non-English speakers due to the 
complexities of distinguishing HL from limited English proficiency (LEP). We examined 
comprehension of label instructions via experimental ‘role-play’ scenarios rather than actual 
use, and real world behavior could differ from our results. On one hand, the experimental 
tasks could have had limited salience for participants in relation to their current health or 
concerns, whereas real world behavior could be safer when health concerns are immediate. 
On the other hand, participants could have been more careful under experimental conditions, 
raising concerns about whether real-world behavior could pose even greater risk than that 
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observed here. This study did not assess where teens obtain medicines or whether parents 
were aware of their child’s medicine use. Although we selected our recruitment sites and 
sample quotas to reflect census and local demographic characteristics, the results of our 
study in one community may have limited generalizability to all adolescents. However, the 
demographic characteristics of our sample are representative of the sample frame,(24) and 
the frequency of reported OTC use in our sample of young people is consistent with prior 
studies in similar age groups.(8, 9) Ours is the first study, to our best knowledge, to examine 
questions of OTC medicine use and understanding of label instructions for acetaminophen 
among adolescents and young adults in association with health literacy.
In summary, there are serious safety concerns associated with OTC products, and individuals 
with limited health literacy may face disproportionate risk of unsafe use due to confusion 
and misunderstanding of label information. However, this risk is not limited to those whose 
health literacy is limited -- those with adequate health literacy also face considerable risk. To 
improve safety for all users of OTC medicines, there is a need for better labeling and public 
health information about the importance of information on medicine labels, and for 
complementary educational efforts to teach how to decode label information to better 
recognize active ingredients and understand dosing instructions. Existing evidence that 
certain formats for communicating medicine information can improve comprehension(25) 
should inform such efforts.
Clinicians and parents must work together to provide developmentally-appropriate 
opportunities throughout adolescence – within clinical encounters and beyond --for learning, 
modeling and rehearsal, and acquisition of autonomous skills for safe use of acetaminophen.
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Table 1
Demographic Characteristics by Literacy Level:
Characteristic All Participants (n=266)
Literacy Level
* p valueLimited (n=96) Adequate (n=170)
Age, Mean years (SD) 18.6 (2.0) 18.4 (1.9) 18.8 (2.0) 0.17
 16–17 33.1 36.5 31.2 0.65
 18–19 38.4 35.4 40.0
 20–23 28.6 28.1 28.8
Gender 0.19
 Male 43.6 49.0 40.6
 Female 56.4 51.0 59.4
Race/Ethnicity <0.001
 Non-Hispanic White 47.4 27.1 58.8
 Non-Hispanic Black 32.3 51.0 21.8
 Hispanic 13.2 13.5 12.9
 Other 7.1 8.3 6.5
Education <0.001
 < High School 59.4 79.2 48.2
 High School Grad/GED 13.5 9.4 15.9
 Some College 27.1 11.5 35.9
Health Insurance 0.02
 Private 36.1 28.1 40.6
 Public 32.3 43.8 25.9
 Uninsured 14.7 14.6 14.7
 Don’t Know 16.9 13.5 18.8
Used OTC in Last Month 0.005
 Yes 73.7 63.5 79.4
 No 26.3 36.5 20.6
*
Fisher’s exact used for expected cell counts less than 5
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Table 2
Measures of Acetaminophen Understanding by Literacy Level:
Acetaminophen Knowledge Measure All Participants (n=266)
Literacy Level
p value*Limited (n=96) Adequate (n=170)
Active Ingredient <0.001
 Correct (Acetaminophen) 86.1 67.7 96.5
 Incorrect 13.9 32.3 3.5
Number of Pills in 1 Dose <0.001
 Correct 65.0 49.0 74.1
 Under 6.8 7.3 6.5
 Over 13.2 16.7 11.2
 Don’t Know 7.9 15.6 3.5
 Inappropriate 7.1 11.5 4.7
Number of Doses in 1 Day <0.001
 Correct 21.4 16.7 24.1
 Under 8.7 14.6 5.3
 Over 62.8 55.2 67.1
 Don’t Know 3.4 8.3 0.6
 Inappropriate 3.8 5.2 2.9
Minimum Recorded Time Between Doses 0.004
 Correct 75.2 63.5 81.8
 Under 8.7 11.5 7.1
 Over 2.3 2.1 2.4
 Don’t Know 13.9 22.9 8.8
Maximum Daily Dose <0.001
 Correct 53.0 39.6 60.6
 Under 23.3 32.3 18.2
 Over 9.8 5.2 12.4
 Don’t Know 13.9 22.9 8.8 0.002
All Measures Correct or Safe Error
 Yes 15.8 6.3 20.6
 No 84.6 93.8 79.4
Familiarity with & Use of Acetaminophen in Past Month <0.001
 Heard of & used acetaminophen 12.8 4.2 17.7
 Heard of & not used acetaminophen 24.1 12.5 30.6
 NOT heard of & not used acetaminophen 42.1 56.3 34.1
 NOT heard of & used acetaminophen 21.1 27.1 17.7
Ability to Correctly ID Acetaminophen Products <0.001
 All Correctly Identified 54.9 36.5 65.3
 Some Correctly Identified 33.8 34.4 33.5
 None Correctly Identified 11.3 29.2 1.2
*
Fisher’s Exact used for expected cell counts less than 5
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